Variant report
Variant | nsv1015632 |
---|---|
Chromosome Location | chr6:66056747-66114121 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:66060579..66062154-chr6:66063684..66065572,2 | MCF-7 | breast: | |
2 | chr6:66051771..66054306-chr6:66063446..66065850,2 | K562 | blood: | |
3 | chr6:66078369..66080351-chr6:66082016..66084974,2 | K562 | blood: | |
4 | chr6:66060579..66062154-chr6:66063684..66065572,2 | MCF-7 | breast: | |
5 | chr6:66078369..66080351-chr6:66082016..66084974,2 | K562 | blood: | |
6 | chr6:66097248..66097748-chr7:48217360..48217884,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1995442 | chr6:66061452-66061453 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs9345608 | chr6:66061475-66061476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs567031117 | chr6:66061476-66061477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534650324 | chr6:66061502-66061503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554592086 | chr6:66061581-66061582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs375150795 | chr6:66061590-66061591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567142487 | chr6:66061593-66061594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577350737 | chr6:66061605-66061606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs9445514 | chr6:66061618-66061619 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs151263616 | chr6:66061634-66061635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192313613 | chr6:66061656-66061657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552550643 | chr6:66061707-66061708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371913935 | chr6:66061733-66061734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571167612 | chr6:66061738-66061739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559929881 | chr6:66061755-66061756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112414800 | chr6:66061782-66061783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542963494 | chr6:66061788-66061789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545661450 | chr6:66061822-66061823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9453261 | chr6:66061852-66061853 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs528361043 | chr6:66061868-66061869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541681543 | chr6:66061871-66061872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs139314102 | chr6:66061881-66061882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs375252360 | chr6:66061918-66061919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576663203 | chr6:66061922-66061923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs182409043 | chr6:66061936-66061937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538561709 | chr6:66061958-66061959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551068798 | chr6:66061961-66061962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs564408936 | chr6:66061971-66061972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533601475 | chr6:66062013-66062014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs1342609 | chr6:66062019-66062020 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs375914311 | chr6:66062036-66062037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567208616 | chr6:66062050-66062051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs1995441 | chr6:66062084-66062085 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs549649797 | chr6:66062087-66062088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs377019392 | chr6:66062106-66062107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568080698 | chr6:66062133-66062134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536628796 | chr6:66062165-66062166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs77815200 | chr6:66062177-66062178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186767226 | chr6:66062179-66062180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs539660408 | chr6:66062185-66062186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs553874192 | chr6:66076013-66076014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573664763 | chr6:66076032-66076033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs373335199 | chr6:66076047-66076048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181198297 | chr6:66076049-66076050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562687708 | chr6:66076067-66076068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9453280 | chr6:66076077-66076078 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs76275816 | chr6:66076084-66076085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs147454163 | chr6:66076106-66076107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs527723117 | chr6:66076140-66076141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9445530 | chr6:66076141-66076142 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 19212409 | CNVD |
Cancer | 20164919 | CNVD |
Retinitis pigmentosa | 21519034 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:66061400-66062200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr6:66061600-66061800 | Enhancers | Fetal Lung | lung |
3 | chr6:66076000-66077200 | Enhancers | Fetal Stomach | stomach |
4 | chr6:66095800-66097200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
5 | chr6:66096600-66097000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr6:66099200-66099600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr6:66108200-66109200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr6:66109200-66110000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr6:66110000-66110200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |